Impact of the U.S. Food and Drug Administration's Safety Communication on Gabapentinoid-Opioid Coprescription. Academic Article uri icon

Overview

publication date

  • July 4, 2025

Identity

Scopus Document Identifier

  • 105010715933

Digital Object Identifier (DOI)

  • 10.1097/ALN.0000000000005564

PubMed ID

  • 40657940

Additional Document Info

volume

  • 143

issue

  • 3